BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 21, 2026
Home » Topics » In the clinic, BioWorld

In the clinic, BioWorld
In the clinic, BioWorld RSS Feed RSS

In the clinic for Oct. 26, 2022

Oct. 26, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Applied, Astrazeneca, Atai, Avrobio, Can-Fite, Cardiol, Gristone, Imaginab, Inotrem, Oblato, Quadriga, Seelos and Ultimovacs.
Read More

In the clinic for Oct. 25, 2022

Oct. 25, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alpine Immune, Bio-Path, Cincor, Matinas, Mirum, Morphic, NS, Novartis, Phathom, Scholar Rock, Step, Tricida, Vaxcyte, Vaxxinity, Viiv, Viridian, Zentalis.
Read More

In the clinic for Oct. 24, 2022

Oct. 24, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anokion, Hepion Immunic, Incyte, OSE, Summit.
Read More

In the clinic for Oct. 21, 2022

Oct. 21, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: AM-Pharma, Harbour, Iterum, Medicane, Palatin, Spikimm, Talaris, T-knife, Venatorx, Vivacelle, Xeris.
Read More

In the clinic for Oct. 20, 2022

Oct. 20, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abeona, Apogenix, Biovie, Brii, Everest, Ocuterra, Moderna, Plus, Providence, PTC, Radiopharm.
Read More

In the clinic for Oct. 19, 2022

Oct. 19, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 1st Biotherapeutic, Artiva, Atai, Bexion, Caribou, Cyclo, Eirion, Ideaya, Instil, Inxmed, Istari, Lenz, Quoin, Salarius, Telix, Teva, Ultimovacs, Vir.
Read More

In the clinic for Oct. 18, 2022

Oct. 18, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Apnimed, Arrivo, Athira, Bavarian Nordic, Cel-Sci, Clovis, Dare, Enanta, Gracell, Innovant, Kiora, Kintor, Leap, Mendus, Milestone, NGM, Palatin, Revive, Sage, Sorrento, Zynerba.
Read More

In the clinic for Oct. 17, 2022

Oct. 17, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aligos, Alterity, Bio-Thera, Bridgebio, Immune-Onc, Moleculin, Nuance, Verona, Xbiotech..
Read More

In the clinic for Oct. 14, 2022

Oct. 14, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D-Pharma, Agenus, Albireo, Biocorrx, Biontech, Cassava, Compass, Crinetics, Inotrem, Inovio, Novavax, Ocugen, Otonomy, Pfizer, Relmada, Sifi, Siga, Smart Immune, Vectivbio.
Read More

In the clinic for Oct. 13, 2022

Oct. 13, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abivax, Amolyt, Atai, Avidity, Beigene, Cognition, Corcept, Eupraxia, Evgen, Evofem, Frequency, Fulcrum, Genentech, Janux, Junshi, Kinnate, Leap, Novavax, Sangamo.
Read More
Previous 1 2 … 86 87 88 89 90 91 92 93 94 … 166 167 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Wireframe of feet and scale

    GLP-1s need technologies for long-term use

    BioWorld
    For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
  • UTRN gene involved in arthrogryposis, study finds

    BioWorld Science
    Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
  • Blue-gray dollar sign

    HMNC raises $50M series B to prep depression drugs for phase III

    BioWorld
    HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing